EXTON, Pa., Jan. 2, 2024 /PRNewswire/ -- Frontage Laboratories, Inc. today announced that, through its wholly-owned subsidiary Frontage Europe S.r.l., it has completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera).
Frontage Holdings Corp., a contract research organization (CRO) providing science-driven research, analytical, and development services, announced today that Frontage Central Labs has been awarded accreditation from the College of American Pathologists (CAP) after a recent on-site inspection by CAP's Accreditation Programs.
Frontage Laboratories Inc. has opened its custom-built 19,000 square foot laboratory located at 3801 Bay Center Place, Hayward, California.
EXTON, Pa., Sept. 21, 2022 /PRNewswire/ -- Frontage Laboratories, Inc. is pleased to announce the opening of a custom-built 19,000 square foot laboratory located at 3801 Bay Center Place, Hayward California.
Frontage wholly-owned subsidiary Frontage Laboratories has completed the purchase of clinical Phase I-IIa business, Frontage Clinical Services, in the US.
Frontage Shanghai has expanded its early drug discovery services through the acquisition of 70% equity interest in Wuhan Heyan Biomedical Technology Co., Ltd. Heyan Biotech, located in Wuhan Optics Valley, national biotech industry base, provides for target based in vitro pharmacodynamic screening and early pharmacological pharmacodynamic evaluation services in early drug discovery. Technical capabilities include screening of drug targets, customized biological assay development and detection services.
Frontage Laboratories, Inc is a PanaBIOS Trusted Travel Approved COVID-19 Laboratory Testing Provider. The authorized status was granted by Africa CDC, Centres for Disease Control and Prevention. The African Union Commission and the Africa CDC launched the Saving Lives, Economies and Livelihoods campaign to promote hassle-free travel across Africa while, at the same time, preventing cross-border spread of COVID-19 infection.